文献速递泌尿生殖腹部MR

前列腺MRI图像质量对临床显著性前列腺癌诊断性能的影响

Impact of prostate MRI image quality on diagnostic performance for clinically significant prostate cancer (csPCa).
PubMed 文献 · Abdom Radiol (NY) · 2024-06-27

回顾性纳入2021年2月至2022年12月306例有明确病理报告的前列腺MRI患者,以ISUP分级组≥2为临床显著性前列腺癌(csPCa),由三名不同中心放射科医生从十个方面评估图像质量。结果显示高质量图像在轴位T2WI、DWI和DCE上csPCa检出率更高(56.5%至64.3%),PPV更高(72.5%至78.8%),且低质量图像更多见于PI-RADS 3(24.0%至52.9%)而非PI-RADS 4-5(20.6%至39.3%);外周带高质量与低质量图像间csPCa检出率差异有统计学意义(63.5%至75.7% vs 30.0%至50.0%)。结论认为前列腺MRI图像质量可能影响诊断性能,较差图像质量与较低csPCa检出率和PPV相关,可导致放射科医生诊断不明确(PI-RADS 3)增加,尤其对外周带病灶。

要点

  • 高质量图像在轴位T2WI、DWI和DCE上csPCa检出率更高(56.5%至64.3%),PPV更高(72.5%至78.8%)。
  • 低质量图像更多见于PI-RADS 3(24.0%至52.9%)而非PI-RADS 4-5(20.6%至39.3%)。
  • 外周带高质量与低质量图像间csPCa检出率差异有统计学意义(63.5%至75.7% vs 30.0%至50.0%)。

核心结论

  • 前列腺MRI图像质量可能影响诊断性能;较差图像质量与较低csPCa检出率和PPV相关,可导致放射科医生诊断不明确(PI-RADS 3)增加,尤其对外周带病灶。

研究设计与样本

  • 回顾性研究,纳入2021年2月至2022年12月306例有明确病理报告的前列腺MRI患者,病理按国际泌尿病理学会(ISUP)推荐评估,ISUP分级组≥2定义为csPCa。
  • 由三名来自不同中心的放射科医生分别从十个方面对图像质量进行二分类评估,采用Fleiss Kappa评估读者间一致性。

诊断标准与关键数值

  • 轴位T2WI信噪比高质量与低质量图像间csPCa检出率差异有统计学意义(p 0.002)。
  • 轴位T2WI伪影存在与否高质量与低质量图像间csPCa检出率差异有统计学意义(p 0.044)。
  • DWI伪影存在与否高质量与低质量图像间csPCa检出率差异有统计学意义(p < 0.001)。
  • DWI与T2WI图像匹配程度高质量与低质量图像间csPCa检出率差异有统计学意义(p < 0.001)。
  • PI-RADS 3中低质量图像比例(24.0%至52.9%)高于PI-RADS 4-5(20.6%至39.3%),轴位T2WI前列腺边界条件(p 0.048)和DWI伪影存在(p 0.001)差异有统计学意义。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: With the widespread clinical application of prostate magnetic resonance imaging (MRI), there has been an increasing demand for lesion detection and accurate diagnosis in prostate MR, which relies heavily on satisfactory image quality. Focusing on the primary sequences involved in Prostate Imaging Reporting and Data System (PI-RADS), this study have evaluated common quality issues in clinical practice (such as signal-to-noise ratio (SNR), artifacts, boundaries, and enhancement). The aim of the study was to determine the impact of image quality on clinically significant prostate cancer (csPCa) detection, positive predictive value (PPV) and radiologist's diagnosis in different sequences and prostate zones.

METHODS: This retrospective study included 306 patients who underwent prostate MRI with definitive pathological reports from February 2021 to December 2022. All histopathological specimens were evaluated according to the recommendations of the International Society of Urological Pathology (ISUP). An ISUP Grade Group ≥ 2 was considered as csPCa. Three radiologists from different centers respectively performed a binary classification assessment of image quality in the following ten aspects: (1) T2WI in the axial plane: SNR, prostate boundary conditions, the presence of artifacts; (2) T2WI in the sagittal or coronal plane: prostate boundary conditions; (3) DWI: SNR, delineation between the peripheral and transition zone, the presence of artifacts, the matching of DWI and T2WI images; (4) DCE: the evaluation of obturator artery enhancement, the evaluation of dynamic contrast enhancement. Fleiss' Kappa was used to determine the inter-reader agreement. Wilson's 95% confidence interval (95% CI) was used to calculate PPV. Chi-square test was used to calculate statistical significance. A p-value < 0.05 was considered statistically significant.

RESULTS: High-quality images had a higher csPCa detection rate (56.5% to 64.3%) in axial T2WI, DWI, and DCE, with significant statistical differences in SNR in axial T2WI (p 0.002), the presence of artifacts in axial T2WI (p 0.044), the presence of artifacts in DWI (p < 0.001), and the matching of DWI and T2WI images (p < 0.001). High-quality images had a higher PPV (72.5% to 78.8%) and showed significant statistical significance in axial T2WI, DWI, and DCE. Additionally, we found that PI-RADS 3 (24.0% to 52.9%) contained more low-quality images compared to PI-RADS 4-5 (20.6% to 39.3%), with significant statistical differences in the prostate boundary conditions in axial T2WI (p 0.048) and the presence of artifacts in DWI (p 0.001). Regarding the relationship between csPCa detection and image quality in different prostate zones, this study found that significant statistical differences were only observed between high- (63.5% to 75.7%) and low-quality (30.0% to 50.0%) images in the peripheral zone (PZ).

CONCLUSION: Prostate MRI quality may have an impact on the diagnostic performance. The poorer image quality is associated with lower csPCa detection rates and PPV, which can lead to an increase in radiologist's ambiguous diagnosis (PI-RADS 3), especially for the lesions located at PZ.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Cheng Y, Zhang L, Wu X, et al. Impact of prostate MRI image quality on diagnostic performance for clinically significant prostate cancer (csPCa). Abdom Radiol (NY). 2024. PMID: 38935093. doi:10.1007/s00261-024-04458-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。